Robert Clinton Hayes

Array ( [id] => 11236558 [patent_doc_number] => 09463190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Methods of treating disease-induced ataxia and non-ataxic imbalance' [patent_app_type] => utility [patent_app_number] => 12/934913 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16735 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12934913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608601 [patent_doc_number] => 07993856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Screening methods using novel BT toxin receptors from lepidopteran insects' [patent_app_type] => utility [patent_app_number] => 12/413830 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15162 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993856.pdf [firstpage_image] =>[orig_patent_app_number] => 12413830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151685 [patent_doc_number] => 08168174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Method of isolating human neuroepithelial precursor cells from human fetal tissue' [patent_app_type] => utility [patent_app_number] => 12/395677 [patent_app_country] => US [patent_app_date] => 2009-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7570 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168174.pdf [firstpage_image] =>[orig_patent_app_number] => 12395677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639322 [patent_doc_number] => 08017349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Human neuronal attachment factor-1' [patent_app_type] => utility [patent_app_number] => 12/364360 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17630 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 349 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017349.pdf [firstpage_image] =>[orig_patent_app_number] => 12364360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563611 [patent_doc_number] => 20090136463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Schwann Cell Bridge Implants and Phosphodiesterase Inhibitors to Stimulate CNS Nerve Regeneration' [patent_app_type] => utility [patent_app_number] => 12/363388 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5690 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136463.pdf [firstpage_image] =>[orig_patent_app_number] => 12363388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15727151 [patent_doc_number] => 10611998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-07 [patent_title] => Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury [patent_app_type] => utility [patent_app_number] => 12/357244 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 15905 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12357244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772715 [patent_doc_number] => 08426673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Pathological animal model for pelvic pain syndrome' [patent_app_type] => utility [patent_app_number] => 12/811338 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4000 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265790 [patent_doc_number] => 20090118475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins' [patent_app_type] => utility [patent_app_number] => 12/345871 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 29065 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118475.pdf [firstpage_image] =>[orig_patent_app_number] => 12345871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936019 [patent_doc_number] => 20110212122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Nerve Growth Factor Conjugates and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/809261 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23442 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212122.pdf [firstpage_image] =>[orig_patent_app_number] => 12809261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608170 [patent_doc_number] => 20100323375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'AGENT AND METHOD FOR DIAGNOSIS ON THE OCCURRENCE OF ALZHEIMER\'S DISEASE OR THE TENDENCY TO DEVELOP ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/747892 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26887 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323375.pdf [firstpage_image] =>[orig_patent_app_number] => 12747892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183978 [patent_doc_number] => 20110123553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination' [patent_app_type] => utility [patent_app_number] => 12/741957 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37143 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123553.pdf [firstpage_image] =>[orig_patent_app_number] => 12741957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452233 [patent_doc_number] => 20090068270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Treatment of degenerated disc with autologous cells' [patent_app_type] => utility [patent_app_number] => 12/291016 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068270.pdf [firstpage_image] =>[orig_patent_app_number] => 12291016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183895 [patent_doc_number] => 08623827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Myelin basic protein peptide composition' [patent_app_type] => utility [patent_app_number] => 12/740976 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 7276 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11462747 [patent_doc_number] => 09579362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Splice variants of GDNF and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/739715 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 23856 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729623 [patent_doc_number] => 08101571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Treatment methods using NGF variants' [patent_app_type] => utility [patent_app_number] => 12/254458 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 17771 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101571.pdf [firstpage_image] =>[orig_patent_app_number] => 12254458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11318518 [patent_doc_number] => 09517253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-13 [patent_title] => 'Compositions for treating multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 12/738706 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6606 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466019 [patent_doc_number] => 20100281550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'FACTOR INVOLVED IN LATENT INFECTION WITH HERPESVIRUS, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/679816 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18851 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20100281550.pdf [firstpage_image] =>[orig_patent_app_number] => 12679816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428541 [patent_doc_number] => 20090087851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Lineage-Restricted Neuronal Precursors' [patent_app_type] => utility [patent_app_number] => 12/233857 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17075 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087851.pdf [firstpage_image] =>[orig_patent_app_number] => 12233857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349328 [patent_doc_number] => 20090004689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Lineage Restricted Glial Precursors from the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 12/209559 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11250 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004689.pdf [firstpage_image] =>[orig_patent_app_number] => 12209559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506884 [patent_doc_number] => 20100210557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'USE OF RFRP, ALONE OR IN COMBINATION WITH NEUROKININ-B, AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677301 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34837 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210557.pdf [firstpage_image] =>[orig_patent_app_number] => 12677301 [rel_patent_id] =>[rel_patent_doc_number] =>)